Pomalidomide-PEG-Bromide is a drug-conjugate composed of pomalidomide, a novel immunomodulatory drug, and polyethylene glycol (PEG). This combination therapy has been shown to be effective in treating multiple myeloma, a type of cancer that affects the bone marrow. The combination of pomalidomide and PEG-bromide allows for increased drug delivery to cancer cells, resulting in increased efficacy and reduced side effects compared to using pomalidomide alone.
Pomalidomide-PEG-Bromide
| Cat# | Name | Structure | Pricing |
|---|---|---|---|
| AP12997 | Pomalidomide-PEG3-Bromide | Pricing |
